RGD-peptides modifying dexamethasone: to enhance the anti-inflammatory efficacy and limit the risk of osteoporosis

MedChemComm

Volumn 6, Issue 7, 2015, Pages 1345-1351

  Yu, Hualong ^a   Mei, Shenghui ^a   Zhao, Li ^b   Zhao, Ming ^a,c   Wang, Yuji ^a   Zhu, Haimei ^a   Wang, Yaonan ^a   Wu, Jianhui ^a   Cui, Chunying ^a   Xu, Wenyun ^a   Peng, Shiqi ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b JIANGXI NORMAL UNIVERSITY   (China)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTYLPHENYLALANINE DEXAMETHASONE; ARGINYLGLYCYLASPARTYLSERINE; ARGINYLGLYCYLASPARTYLSERINE DEXAMETHASONE; ARGINYLGLYCYLASPARTYLVALINE DEXAMETHASONE; DEXAMETHASONE; NANOPARTICLE; POLYPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE DENSITY; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DNA REPLICATION; DOWN REGULATION; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG STRUCTURE; DRUG SYNTHESIS; EAR EDEMA; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; TREATMENT DURATION;

MUS; RICE GALL DWARF VIRUS;

EID: 84936859151     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c5md00215j     Document Type: Article

References (33)

1. P. J. Barnes Glucocorticosteroids: Current and future directions Br. J. Pharmacol. 2011 163 29 43
2. P. J. Barnes How corticosteroids control inflammation: Quintiles prize lecture 2005 Br. J. Pharmacol. 2009 148 245 254
3. P. J. Barnes Mechanisms and resistance in glucocorticoid control of inflammation J. Steroid Biochem. Mol. Biol. 2010 120 76 85
4. R. A. Bronicki C. L. Backer H. P. Baden C. Mavroudis S. E. Crawford Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children Ann. Thorac. Surg. 2000 69 1490 1495
5. S. Benedetti B. Pirola P. L. Poliani L. Cajola B. Pollo R. Bagnati L. Magrassi P. Tunici G. Finocchiaro Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas Gene Ther. 2003 10 188 192
6. J. A. Patel M. Kunimoto T. Sim T. Chonmaitree F. Schmalstieg EFFECT OF DEXAMETHASONE (DEX) AND RIBAVIRIN (RIB) ON CYTOKINE PRODUCTION BY RESPIRATORY SYNCYTIAL VIRUS (RSV)-INFECTED EPITHELIAL-CELLS Pediatr. Res. 1994 35 A191
7. R. Goldbach-Mansky P. E. Lipsky New Concepts in the Treatment of Rheumatoid Arthritis Annu. Rev. Med. 2003 54 197 216
8. R. F. van Vollenhoven Treatment of rheumatoid arthritis: state of the art 2009 Nat. Rev. Rheumatol. 2009 5 531 541
9. J. R. Kirwan The effect of glucocorticoids on joint destruction in rheumatoid arthritis N. Engl. J. Med. 1995 333 142 147
10. R. Gupta D. P. Jindal G. Kumar Corticosteroids: the mainstay in asthma therapy Bioorg. Med. Chem. 2004 12 6331 6342
11. F. Buttgereit K. G. Saag M. Cutolo J. A. P. da Silva J. W. J. Bijlsma The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis Scand. J. Rheumatol. 2005 34 14 21
12. H. Schäcke W. D. Döcke K. Asadullah Mechanisms involved in the side effects of glucocorticoids Pharmacol. Ther. 2002 96 23 43
13. J. A. Kanis M. Stevenson E. V. McCloskey S. Davis M. Lloyd-Jones Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis Health Technol. Assess. 2007 11 iii 89
14. L. C. Hofbauer M. Rauner Minireview: live and let die: molecular effects of glucocorticoids on bone cells Mol. Endocrinol. 2009 23 1525 1531
15. R. S. Weinstein Glucocorticoid-induced bone disease N. Engl. J. Med. 2011 365 62 70
16. M. Bartneck F. M. Petersa K. T. Warzecha M. Bienert L. van Bloois C. Trautwein T. Lammers F. Tacke Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages Nanomedicine 2014 10 1209 1220
17. I. Venditti L. Fontana I. Fratoddi C. Battocchio C. Cametti S. Sennato F. Mura F. Sciubba M. Delfini M. V. Russo Direct interaction of hydrophilic gold nanoparticles with dexamethasone drug: loading and release study J. Colloid Interface Sci. 2014 418 52 60
18. L. Quan F. Yuan X. Liu J. Huang Y. Alnouti D. Wang Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl) methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model Mol. Pharmaceutics 2010 7 1041 1049
19. R. Mateen T. Hoare Carboxymethyl and hydrazide functionalized β-cyclodextrin derivatives: A systematic investigation of complexation behaviours with the model hydrophobic drug dexamethasone Int. J. Pharm. 2014 472 315 326
20. X. Liu L. Quan J. Tian F. C. Laquer Syntheses of Click PEG- Dexamethasone Conjugates for the Treatment of Rheumatoid Arthritis Biomacromolecules 2010 11 2621 2628
21. Z. Zhang Y. Lai L. Yu J. Ding Effects of immobilizing sites of RGD peptides in amphiphilic block copolymers on efficacy of cell adhesion Biomaterials 2010 31 7873 7882
22. K. M. Hennessy W. C. Clem M. C. Phipps A. A. Sawyer F. M. Shaikh S. L. Bellis The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials Biomaterials 2008 29 3075 3083
23. R. M. Ahmed R. Jayakumar Peripheral nerve regeneration in RGD peptide incorporated collagen tubes Brain Res. 2003 993 208 216
24. S. Kalinina H. Gliemann M. López-García A. Petershans J. Auernheimer T. Schimmel M. Bruns A. Schambony H. Kessler D. Wedlich Isothiocyanate-functionalized RGD peptides for tailoring cell-adhesive surface patterns Biomaterials 2008 29 3004 3013
25. D. S. Hwang S. B. Sim H. J. Cha Cell adhesion biomaterial based on mussel adhesive protein fused with RGD peptide Biomaterials 2007 28 4039 4046
26. K. Hagisawa T. Nishioka R. Suzuki T. Takizawa K. Maruyama B. Takase M. Ishihara A. Kurita N. Yoshimoto F. Ohsuzu M. Kikuchi Enhancement of ultrasonic thrombus imaging using novel liposomal bubbles targeting activated platelet glycoprotein IIb/IIIa complex-in vitro and in vivo study Int. J. Cardiol. 2011 152 202 206
27. J. Sánchez-Cortés M. Mrksich The platelet integrin αIIbβ3 Binds to the RGD and AGD motifs in fibrinogen Chem. Biol. 2009 16 990 1000
28. D. E. Barre Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor Thromb. Res. 2007 119 601 607
29. M. Kupczyk Z. Kurmanowska I. Kuprÿ-Lipińska M. Bocheńska-Marciniak P. Kuna Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge Respir. Med. 2010 104 1404 1409
30. Y. Li J. Gu X. Zou J. Wu M. Zhang J. Jiang D. Qin J. Zhou B. Liu Y. Zhu X. Jia L. Feng R. Wang The anti-lung cancer activities of steroidal saponins of P. polyphylla Smith var. chinensis (Franch.) Hara through enhanced immunostimulation in experimentalLewis tumor-bearing C57BL/6 mice and induction of apoptosis in the A549 cell line Molecules 2013 18 12916 12936
31. H. Líbalová S. Krčková K. Uhlířová J. Kléma M. Ciganek P. Rössner Jr. R. J. Šrám J. Vondráček M. Machala J. Topinka Analysis of gene expression changes in A549 cells induced by organic compounds from respirable air particles Mutat. Res. 2014 770 94 105
32. M. Durga S. Nathiya A. Rajasekar T. Devasena Effects of ultrafine petrol exhaust particles on cytotoxicity, oxidative stress generation, DNA damage and inflammation in human A549 lung cells and murine RAW 264.7 macrophages Environ. Toxicol. Pharmacol. 2014 38 518 530
33. Y. Mizushina I. Kuriyama A. Yamazaki T. Akashi H. Yoshida Cycloartenyl trans-ferulate, a component of the bran byproduct of sake-brewing rice, inhibits mammalian DNA polymerase and suppresses inflammation Food Chem. 2013 141 1000 1007